Volume 18 - Issue 9 - September, 2006
Feature
Clinical Images
08/01/2008
Nichole Polin, MD, Dmitriy Feldman, MD, Srihari S. Naidu, MD
Nichole Polin, MD, Dmitriy Feldman, ...
Case Presentation. A 39-year-old female with chronic hypertension presented with a 1-year history of progressive dyspnea. Echocardiography 6 months prior to admission confirmed hypertrophic obstructive cardiomyopathy (HOCM), and high-dose...
Case Presentation. A 39-year-old female with chronic hypertension presented with a 1-year history of progressive dyspnea. Echocardiography 6 months prior to admission confirmed hypertrophic obstructive cardiomyopathy (HOCM), and high-dose...
Case Presentation. A 39-year-old...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
08/01/2008
Kamal Chitkara, MRCP, Kai Hogrefe, MD, Mariuca Vasa-Nicotera, MD, Neil Swanson, MD,
Anthony H. Gershlick, FRCP
Kamal Chitkara, MRCP, Kai Hogrefe, M...
Coronary stent placement is the most commonly employed technique for percutaneous treatment of atherosclerotic heart disease. It accounts for about 75% of the procedures performed worldwide.1 In comparison to conventional balloon angioplasty,...
Coronary stent placement is the most commonly employed technique for percutaneous treatment of atherosclerotic heart disease. It accounts for about 75% of the procedures performed worldwide.1 In comparison to conventional balloon angioplasty,...
Coronary stent placement is the...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
08/01/2008
Michael Billinger, MD, Felix Buddeberg, MD, Jeffrey A. Hubbell, PhD, Donald L. Elbert, PhD, Thomas Schaffner, MD, Daniel Mettler, VDM, Stephan Windecker, MD, Bernhard Meier, MD, Otto M. Hess, MD
Michael Billinger, MD, Felix Buddeber...
Attempts to reduce neointimal proliferation following coronary artery stent implantation have focused on stent coatings with or without local drug delivery. Polymers provide some unique features, which determine their use as coating material:...
Attempts to reduce neointimal proliferation following coronary artery stent implantation have focused on stent coatings with or without local drug delivery. Polymers provide some unique features, which determine their use as coating material:...
Attempts to reduce neointimal...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
08/01/2008
*Sunil V. Rao, MD, Emily Honeycutt, MD, David Kandzari, MD
*Sunil V. Rao, MD, Emily Honeycutt, ...
Treatment with drug-eluting stents (DES) has revolutionized percutaneous coronary intervention (PCI) due to their substantial efficacy in reducing restenosis and the need for repeat revascularization procedures. Despite this benefit, the...
Treatment with drug-eluting stents (DES) has revolutionized percutaneous coronary intervention (PCI) due to their substantial efficacy in reducing restenosis and the need for repeat revascularization procedures. Despite this benefit, the...
Treatment with drug-eluting...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
08/01/2008
David E. Kandzari, MD, Robert H. Tuttle, MSPH, James P. Zidar, MD, James G. Jollis,
David E. Kandzari, MD, Robert H. Tut...
Randomized clinical trials evaluating coronary stents versus balloon angioplasty have demonstrated marked improvements in the short- and long-term safety and efficacy of percutaneous coronary intervention (PCI) by reducing restenosis and the...
Randomized clinical trials evaluating coronary stents versus balloon angioplasty have demonstrated marked improvements in the short- and long-term safety and efficacy of percutaneous coronary intervention (PCI) by reducing restenosis and the...
Randomized clinical trials...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
08/01/2008
Pranab Das, MD, *David J. Moliterno, MD, Richard Charnigo, MD, Debabrata Mukherjee, MD,
Steven R. Steinhubl, MD, J. Darrell Sneed, MD, David C. Booth, MD, Khaled M. Ziada, MD
Pranab Das, MD, *David J. Moliterno,...
Several randomized trials have demonstrated the efficacy of drug-eluting stents (DES) in reducing restenosis and the need for target vessel revascularization (TVR) in comparison to bare metal stents (BMS).1-3 Patient and lesion subsets...
Several randomized trials have demonstrated the efficacy of drug-eluting stents (DES) in reducing restenosis and the need for target vessel revascularization (TVR) in comparison to bare metal stents (BMS).1-3 Patient and lesion subsets...
Several randomized trials have...
08/01/2008
Journal of Invasive Cardiology
Department
Letters to the Editor
08/01/2008
1Robert S. Dieter, MD, RVT, 2Sarfraz Sidhu, MD, 3Pat Mannebach, MD
1Robert S. Dieter, MD, RVT, 2Sarfraz...
Dear Editor,
We read with great interest the report by Mejia et al entitled “Left Main Coronary Embolism” in the June 2006 issue of the Journal of Invasive Cardiology. We had a similar case of an acute myocardial infarction secondary to left...
Dear Editor,
We read with great interest the report by Mejia et al entitled “Left Main Coronary Embolism” in the June 2006 issue of the Journal of Invasive Cardiology. We had a similar case of an acute myocardial infarction secondary to left...
Dear Editor,
We read with great...
08/01/2008
Journal of Invasive Cardiology
Letters to the Editor
08/01/2008
Is There a Need for a Technology that Will Promote
Positive Remodeling and Mild Plaque Increase?
“Favorable vessel remodeling observed in this study is consistent with the result of the previous gamma radiation study noted above,1 as well...
Is There a Need for a Technology that Will Promote
Positive Remodeling and Mild Plaque Increase?
“Favorable vessel remodeling observed in this study is consistent with the result of the previous gamma radiation study noted above,1 as well...
Is There a Need for a Technology...
08/01/2008
Journal of Invasive Cardiology
Insights
Commentary
08/01/2008
Shahid Aziz, MRCP and David Ramsdale, MD, FRCP
Shahid Aziz, MRCP and David Ramsdale,...
Ideally, cardiologists would like a stent that is easy to deliver, causes no acute thrombosis, provides insignificant late loss due to intimal hyperplasia and offers no risk of late thrombosis should antiplatelet therapy have to be withdrawn....
Ideally, cardiologists would like a stent that is easy to deliver, causes no acute thrombosis, provides insignificant late loss due to intimal hyperplasia and offers no risk of late thrombosis should antiplatelet therapy have to be withdrawn....
Ideally, cardiologists would...
08/01/2008
Journal of Invasive Cardiology
Commentary
08/01/2008
Anthony A. Bavry, MD, MPH and Deepak L. Bhatt, MD
Anthony A. Bavry, MD, MPH and Deepak ...
Urgent coronary reperfusion unequivocally saves lives in the setting of acute coronary syndromes, however for most patients, the goal of percutaneous coronary intervention remains the control of anginal symptoms.1,2 As a standalone procedure,...
Urgent coronary reperfusion unequivocally saves lives in the setting of acute coronary syndromes, however for most patients, the goal of percutaneous coronary intervention remains the control of anginal symptoms.1,2 As a standalone procedure,...
Urgent coronary reperfusion...
08/01/2008
Journal of Invasive Cardiology
